BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 28875683)

  • 1. In vivo comprehensive metabolite profiling of esculetin and esculin derived from chicory in hyperuricemia rats using ultra-high-performance liquid chromatography coupled with quadrupole-orbitrap high-resolution mass spectrometry.
    Lv Z; Wang B; Wang B; Zhang H
    J Sep Sci; 2024 Jan; 47(1):e2300664. PubMed ID: 38010472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pseudo-targeted metabolomics for discovery of potential biomarkers of cardiac hypertrophy in rats.
    Liu B; Du Z; Zhang W; Guo X; Lu Y; Jiang Y; Tu P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jun; 1240():124133. PubMed ID: 38733887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC-MS-Based Metabolomics Reveals the Mechanism of Protection of Berberine against Indomethacin-Induced Gastric Injury in Rats.
    Xu J; Yang XW
    Molecules; 2024 Feb; 29(5):. PubMed ID: 38474567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodine-131 intervention in hyperthyroidism with hepatic insufficiency: Metabolomic evaluation.
    Luo Z; Lei Y; Zeng L; Chen X; Liu S; Zhang Q
    Biomed Pharmacother; 2024 Apr; 173():116300. PubMed ID: 38430629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolome and microbiome of chronic periapical periodontitis in permanent anterior teeth: a pilot study.
    Huang Y; Zhou P; Liu S; Duan W; Zhang Q; Lu Y; Wei X
    BMC Oral Health; 2021 Nov; 21(1):599. PubMed ID: 34814909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Throughput Untargeted Serum Metabolomics Analysis of Hyperuricemia Patients by UPLC-Q-TOF/MS.
    Qin N; Jiang Y; Shi W; Wang L; Kong L; Wang C; Guo Y; Zhang J; Ma Q
    Evid Based Complement Alternat Med; 2021; 2021():5524772. PubMed ID: 34234835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipidomics to investigate the pharmacologic mechanisms of ginkgo folium in the hyperuricemic rat model.
    Zhang S; Zhuang J; Yue G; Wang Y; Liu M; Zhang B; Du Z; Ma Q
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():407-415. PubMed ID: 28672255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipidomics coupled with pathway analysis characterizes serum metabolic changes in response to potassium oxonate induced hyperuricemic rats.
    Yang F; Liu M; Qin N; Li S; Yu M; Wang C; Ma Q
    Lipids Health Dis; 2019 May; 18(1):112. PubMed ID: 31077208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on chemical constituents of herbal formula Er Miao Wan and GC-MS based metabolomics approach to evaluate its therapeutic effects on hyperuricemic rats.
    Huang B; Hu X; Wang J; Li P; Chen J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jun; 1118-1119():101-108. PubMed ID: 31030102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UPLC/Q-TOF-MS/MS-based metabolomics revealed the lipid-lowering effect of Ilicis Rotundae Cortex on high-fat diet induced hyperlipidemia rats.
    Yang B; Xuan S; Ruan Q; Jiang S; Cui H; Zhu L; Luo X; Jin J; Zhao Z
    J Ethnopharmacol; 2020 Jun; 256():112784. PubMed ID: 32222573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted and non-targeted metabolomics uncovering the effects of Er-Miao-Wan formula on rats with hyperuricemia.
    Gu C; Hu X; Shan B; Wu X; Chen J
    J Pharm Biomed Anal; 2023 Mar; 226():115246. PubMed ID: 36731256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipid metabolomics in serum of hyperuricemic rats induced by fructose based on UPC²-Q/TOF-MS].
    Zhang SL; Wang YP; Du ZX; Xue M; Zhang J; Ma Q
    Zhongguo Zhong Yao Za Zhi; 2016 Mar; 41(6):1135-1139. PubMed ID: 28875683
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.